CMS challenge model
VESO Vikan has established a challenge model for CMS/ PMCV.
We have been working for a long time to develop a challenge model for CMS (cardiomyopathy syndrome). We have finally succeeded, and are able to offer challenge with PMCV (piscine myocarditis virus) by intraperitoneal injection. After 9 weeks, histopathological changes in the heart consistent with CMS can be seen.